Plasma MMP-1 Expression as a Prognostic Factor in Colon Cancer
Authors:
Open Access
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Journal of Surgical Research
- Vol. 266, 254-260
Abstract
No abstract availableKeywords
Funding Information
- Swedish Cancer Society
- Region Halland
- Sahlgrenska Universitetssjukhuset
This publication has 32 references indexed in Scilit:
- Validation of the seventh edition of the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical centre in KoreaColorectal Disease, 2011
- Serum Matrix-Metalloproteinase-1 is a Bona Fide Prognostic Marker for Colorectal CancerAnnals of Surgical Oncology, 2010
- A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: The significance of matrix metalloproteinase-1 expression as a predictor of liver metastasisScandinavian Journal of Gastroenterology, 2010
- Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patientsInternational Journal of Cancer, 2007
- The Biochemical, Biological, and Pathological Kaleidoscope of Cell Surface Substrates Processed by Matrix MetalloproteinasesCritical Reviews in Biochemistry and Molecular Biology, 2007
- Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition StagingJNCI: Journal of the National Cancer Institute, 2004
- Efficacy of Oral Adjuvant Therapy After Resection of Colorectal Cancer: 5-Year Results From Three Randomized TrialsJournal of Clinical Oncology, 2004
- Use of plasma MMP‐2 and MMP‐9 levels as a surrogate for tumour expression in colorectal cancer patientsInternational Journal of Cancer, 2003
- Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancerExperimental Dermatology, 2003
- Expression of Matrix Metalloproteinase-1 in Human Colorectal CarcinomaLaboratory Investigation, 2000